Spontaneous splenic rupture in patient with metastatic melanoma treated with vemurafenib

BACKGROUND: BRAF inhibitors such as vemurafenib are a new family of biological drugs, recently available to treat metastatic malignant melanoma. METHODS: We present the case of a 38-year-old man affected by metastatic melanoma who had been under treatment with vemurafenib for a few days. The patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellani, Elisa, Covarelli, Piero, Boselli, Carlo, Cirocchi, Roberto, Rulli, Antonio, Barberini, Francesco, Caracappa, Daniela, Cini, Carla, Desiderio, Jacopo, Burini, Gloria, Noya, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502264/
https://www.ncbi.nlm.nih.gov/pubmed/22846499
http://dx.doi.org/10.1186/1477-7819-10-155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502264/
https://www.ncbi.nlm.nih.gov/pubmed/22846499
http://dx.doi.org/10.1186/1477-7819-10-155

Ejemplares similares